AGPU is the ticker for Axe Compute Inc., a micro-cap provider of GPU compute capacity for artificial intelligence workloads, alongside a legacy drug-discovery services business. The company was formerly known as Predictive Oncology Inc. before renaming in December 2025.
Unlike larger names with broad street coverage, Axe Compute has almost no institutional sell-side research. The only clearly attributable price target identified is $20, set by Jones Trading when it initiated coverage with a Buy rating on September 26, 2026. Because there is only one named target, this figure cannot be presented as an analyst consensus or average analyst price target. Separately, Weiss Ratings carries a Sell rating, reflecting a sharply different view of the same shares. This wide divergence is typical of thinly covered micro-caps, where a single analyst's stock forecast can dominate available data. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At its most recent verified close, Axe Compute traded near $6.98, giving the company a market capitalization of roughly $80 million. From that level, a move to $20 implies upside of about 185%, which is a very large required move. The shares have traded in an extraordinarily wide 52-week range of roughly $1.03 to $13.49, so the stock has previously approached — though not reached — the $20 mark's vicinity in percentage terms only briefly, and sits well below its prior peak.
The path to any higher valuation runs through execution. Management has disclosed a signed, 36-month, $260 million build for 2,304 NVDA B300 GPUs targeted for deployment, expected to generate roughly $21 million in quarterly revenue once live, and cites a pipeline of more than 36,000 GPUs representing over $4.3 billion in total contract value. Converting these commitments into recognized revenue is the core question for the stock forecast.
The prior 52-week high near $13.49 stands as the most meaningful resistance level, representing the stock's recent peak before its pullback toward $7. Below that, round-number levels such as $10 and $13 could act as psychological resistance zones on any recovery. On the downside, the $6.50-to-$7.00 area has served as recent support, while the broader multi-year range low near $1 underscores how far this stock can fall when sentiment shifts. These durable levels matter because $20 sits well above every recorded milestone except the most speculative intraday prints. From what I see, these levels help frame realistic entry and exit considerations.
Analyst price targets typically reflect a research horizon of roughly 12 months, though with a single covering analyst no meaningful range of horizons exists here. Investors weighing the $20 level should track quarterly earnings and the progression of the compute build, any updates on contract closings and installments, cash position and operating cash flow, changes to the single analyst target or new initiations, and broader AI-infrastructure spending trends. The gap between an aggressive single-analyst target and current trading is wide enough that even favorable execution may take considerable time to reflect in the price. I’m watching this closely for any signs of progress on the major contracts.
Tickeron's AI Daily Buy/Sell Signals uses artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a high-beta micro-cap like Axe Compute, such tools can help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual chart review alone. Traders interested in a systematic, data-driven approach to daily signal generation may find it a useful complement to their own research.
Whether AGPU can reach $20 depends on execution far more than on any single analyst's stock price target. The $20 level is a stretch objective requiring roughly a 185% advance from current levels, drawn from one Jones Trading Buy initiation rather than a broad consensus. Support comes from a substantial compute contract and an expansive pipeline, but those positives are balanced against minimal current revenue, large losses, shrinking cash, extreme volatility, and an outright Sell view from another ratings source. The central variables to watch are deployment milestones, contract conversions, and cash preservation, none of which offer any guarantee that the target will be reached.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Stochastic Oscillator for AGPU moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 44 similar instances where the indicator exited the overbought zone. In 41 of the 44 cases the stock moved lower. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AGPU as a result. In 84 of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
AGPU moved below its 50-day moving average on October 13, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AGPU crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AGPU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AGPU entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AGPU's RSI Indicator exited the oversold zone, 41 of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Moving Average Convergence Divergence (MACD) for AGPU just turned positive on November 11, 2026. Looking at past instances where AGPU's MACD turned positive, the stock continued to rise in 42 of 45 cases over the following month. The odds of a continued upward trend are 90%.
Following a +17.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where AGPU advanced for three days, in 193 of 236 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
AGPU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.291) is normal, around the industry mean (16.188). P/E Ratio (-1.024) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (86.957) is also within normal values, averaging (103.301).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. AGPU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AGPU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company, which engages in the manufacture and distribution of healthcare products, and provision of related services.
Industry ComputerCommunications